Genscript Biotech Corp (GNNSF) Full Year 2025 Earnings Call Highlights: Record Revenue Growth ... [Yahoo! Finance]
Legend Biotech Corporation - American Depositary Shares (LEGN)
Company Research
Source: Yahoo! Finance
This article first appeared on GuruFocus Group Revenue: Increased by 61.4% year over year to $959.5 million. Adjusted Net Profit: Reached nearly $230 million. Life Science Group Revenue: Grew 14.8% year over year to $522.1 million. ProBio Revenue: Achieved 309.1% growth to $388.7 million, including nearly $280 million from a Lenovo license deal. Bestzyme Revenue: Grew by 7.9% year over year to $58 million. Adjusted Gross Profit Margin: Adjusted Operating Profit: $95.4 million. Legend Biotech Adjusted Net Loss: Narrowed to $33.1 million. Impairment Loss: $398.1 million due to investment in Legend Biotech. Share of Loss from Legend Biotech: $310.4 million. R&D Expenses: Approximately 9% of total revenue. SG&A Expenses: Increased due to investments in Europe and North America. Warning! GuruFocus has detected 9 Warning Signs with GNNSF. Is GNNSF fairly valued? Test your thesis with our free DCF calculator. Release Date: March 15, 2026 For the complete tran
Show less
Read more
Impact Snapshot
Event Time:
LEGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LEGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LEGN alerts
High impacting Legend Biotech Corporation - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
LEGN
News
- GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality GrowthPR Newswire
- GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality GrowthPR Newswire
- GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality GrowthPR Newswire
- Legend Biotech (LEGN) was upgraded by Truist Financial Corporation from "hold" to "strong-buy".MarketBeat
- Legend Biotech Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
LEGN
Sec Filings
- 3/10/26 - Form 20-F
- 3/10/26 - Form 6-K
- 2/6/26 - Form 6-K
- LEGN's page on the SEC website